Smallpox vaccination: Risk considerations for patients with atopic dermatitis - 01/09/11
Abstract |
As the threat of bioterrorism with pathogenic microbes such as smallpox virus (Variola major) increases, the question of widespread voluntary vaccination with smallpox (vaccinia) vaccines is being carefully considered. A major challenge lies in the ability to protect the population from the disease while minimizing the considerable side effects from the vaccine. Individuals with active or quiescent atopic dermatitis are at increased risk for vaccinia complications. The nature of these complications and other considerations are summarized in this rostrum. (J Allergy Clin Immunol 2002;110:357-65.)
Le texte complet de cet article est disponible en PDF.Keywords : Atopic dermatitis, eczema, smallpox, vaccinia, T cells
Abbreviations : AD, CF, EV, HI, HSV
Plan
 | The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army, the Department of Defense, The National Jewish Medical and Research Center, or The Journal of Allergy and Clinical Immunology . |
| Reprint requests: Donald Y. M. Leung, MD, PhD, National Jewish Medical Research Center, 1400 Jackson Street, Room K926i, Denver, CO 80206. |
Vol 110 - N° 3
P. 357-365 - septembre 2002 Retour au numéro
Article précédent
- Oxidative stress in allergic respiratory diseases
- Russell P. Bowler, James D. Crapo
- Proteasome-dependent regulation of Syk tyrosine kinase levels in human basophils
- Lama A. Youssef, Bridget S. Wilson, Janet M. Oliver
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?